Month: February 2022

There are so many gold IRA options out there that it can be hard to know where to begin. That’s where Gold IRA Etc. comes in! The new report aims to showcase the most effective ways for you to protect your nest egg savings with easy-to-liquidate assets. Companies discussed in the report include Goldco, Birch Gold Group, Augusta Precious Metals, and Regal Assets. Diversify your assets at: https://www.goldiraetc.comBy reading the new report, you can make a more informed decision about your future. It emphasizes the central benefits of each account option, and simplifies the process for you. Goldco is rated the highest in the report for its high-quality customer support, streamlined rollover process, and low-fee model. This makes it well suited to those seeking a trustworthy and reliable platform. Contrasting this, Birch Gold Group has over...

One of the four production lines at Hydro’s part-owned aluminium plant Albras in Brazil was shut down Saturday morning local time due to an internal power distribution failure. The power distribution failure occurred within one potline at Albras, consequently leading to a shutdown of the affected potline. The affected potline produces 110,000 tonnes of liquid aluminium annually.   The other three lines at Albras were not affected and are running as normal. It remains too early to assess financial implications from the incident, as well as timing for restart. Albras will investigate the root cause for the shutdown. Albras has a total production capacity of 460,000 tonnes per year. Hydro owns 51% of Albras, while the remaining 49% is owned by Nippon Amazon Aluminium Co. Ltd. Albras is located in the city of Barcarena in Pará State in northern...

TORONTO, Feb. 18, 2022 (GLOBE NEWSWIRE) — EnviroGold Global Limited (CSE: NVRO | OTCQB: RGOZF | FSE: YGK) (“EnviroGold Global” or the “Company“), a Clean Technology Company accelerating the world’s transition to a circular-resource economy through the production of Metals Without Mining, is pleased to announce the execution of a binding, definitive agreement (the “Definitive Agreement”) with Hellyer Gold Mines Pty Ltd (“Hellyer Gold Mines” or “HGM”) to reprocess the tailings owned by HGM (the “Hellyer Tailings Reprocessing Project“ or the “Hellyer Tailings Project”) at the Hellyer Gold Mine, Tasmania, Australia. The execution of the transaction cements a major growth catalyst for EnviroGold Global, paving the way for finalization of project financing negotiations and materially advancing the Company’s accelerated pathway towards...

WALTHAM, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc. (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced a Chief Executive Officer succession plan. Current Adagio CEO Tillman Gerngross, Ph.D. has communicated to the Chairperson of the Board of Directors of Adagio that he agreed in principle to resign from his position as CEO. Upon Dr. Gerngross’s departure from the Company, the Board intends to appoint Mr. David Hering, M.B.A., who has served as the Company’s Chief Operating Officer, as Interim Chief Executive Officer of the Company. Dr. Gerngross also agreed to transfer the duties of the Chief Executive Officer to Mr. Hering. “We have built a strong...

VANCOUVER, British Columbia, Feb. 18, 2022 (GLOBE NEWSWIRE) — North Arrow Minerals Inc. (TSXV-NAR) (“North Arrow”) announces that it has agreed with Anglo Celtic Exploration Ltd (“Anglo Celtic”) to extend by one year the term of an unsecured loan of $400,000 (the “Loan”) provided to North Arrow and first announced on February 17, 2021. Under terms of the amendment to the loan agreement (the “Agreement”) the revised date by which any outstanding balance on the loan must be repaid in full is February 16, 2023. All other terms related to the Loan and the Agreement remain the same. As further consideration for agreeing to extend the Loan, North Arrow shall issue to Anglo Celtic 1,000,000 share purchase warrants (the “Bonus Warrants”). Each Bonus Warrant will allow Anglo Celtic to purchase one common share (a “Warrant Share”) at a price...

MALVERN, Pa., Feb. 18, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced that the U.S. Food and Drug Administration (FDA) has lifted its clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as COVAXIN™ outside the United States. COVAXIN™ is a whole-virion inactivated COVID-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades. “We are pleased to be able to move our clinical program for COVAXIN™ forward, which we hope will bring us closer to offering an alternative COVID-19 vaccine,” said Dr. Shankar Musunuri,...